Company NeoGenomics, Inc. OTC Bulletin Board

Equities

US64049M2098

Healthcare Facilities & Services

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Medical & Diagnostic Laboratories

Inactive Instrument

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

05-28	NeoGenomics, Inc. to Introduce Comprehensive Lung Solution & Feature Hematopathology Services At ASCO	CI
05-02	North American Morning Briefing : Stock Futures -3-	DJ

NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical cancer testing; interpretation and consultative services; molecular and NGS testing, and comprehensive technical and professional services offering. Its Clinical Services customers include community-based pathology and oncology practices, hospital pathology labs, reference labs, and academic centers. The Advanced Diagnostics segment consist of clinical trials and research, validation laboratory services, and informatics. Its Advanced Diagnostics customers include pharmaceutical companies to whom it provides testing and other services to support their research studies and clinical trials.

USD in Million	2022	Weight	2023	Weight	Delta
Clinical Services 83.8 %	419	82.2 %	496	83.8 %	+18.36%
Advanced Diagnostics 16.2 %	91	17.8 %	96	16.2 %	+5.53%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	510	100.0 %	592	100.0 %	+16.07%

Managers	Title	Age	Since
Chris Smith CEO	Chief Executive Officer	61	14/08/22
Lynn Tetrault CHM	Chairman	61	11/06/15
Jeffrey Sherman DFI	Director of Finance/CFO	58	06/12/22
Derek Lyle CTO	Chief Tech/Sci/R&D Officer	-	30/06/21
Shashikant Kulkarni CTO	Chief Tech/Sci/R&D Officer	57	06/03/22
Greg Sparks CTO	Chief Tech/Sci/R&D Officer	56	-
Hutan Hashemi CMP	Compliance Officer	45	28/02/22
Forrest Holmes Blocker CTO	Chief Tech/Sci/R&D Officer	-	-
Melody Harris COO	Chief Operating Officer	58	04/12/22
Warren Stone PRN	Corporate Officer/Principal	51	20/11/22

Members of the board	Title	Age	Since
Michael Kelly BRD	Director/Board Member	67	14/07/20
Chris Smith CEO	Chief Executive Officer	61	14/08/22
David Perez BRD	Director/Board Member	63	02/11/22
Anthony Zook BRD	Director/Board Member	63	25/06/23
Lynn Tetrault CHM	Chairman	61	11/06/15
Stephen Kanovsky BRD	Director/Board Member	61	18/07/17
Alison Hannah BRD	Director/Board Member	63	11/06/15
Neil Gunn BRD	Director/Board Member	63	25/06/23
Elizabeth Floegel BRD	Director/Board Member	48	25/06/23

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	127,711,930	126,077,979 ( 98.72 %)	0	98.72 %

Name	Equities	%	Valuation
BlackRock Advisors LLC 14.88 %	19,003,064	14.88 %	261 M $
Vanguard Fiduciary Trust Co. 11.13 %	14,211,019	11.13 %	195 M $
Brown Investment Advisory & Trust Co. 7.572 %	9,669,775	7.572 %	133 M $
T. Rowe Price Investment Management, Inc. 5.370 %	6,857,581	5.370 %	94 M $
Janus Henderson Investors US LLC 4.918 %	6,280,866	4.918 %	86 M $
STATE STREET CORPORATION 3.835 %	4,897,766	3.835 %	67 M $
Greenhouse Funds LLLP 3.442 %	4,396,354	3.442 %	60 M $
Macquarie Investment Management Business Trust 3.150 %	4,023,509	3.150 %	55 M $
First Light Asset Management LLC 2.586 %	3,302,165	2.586 %	45 M $
Schroder Investment Management North America, Inc. 2.431 %	3,104,103	2.431 %	43 M $

NeoGenomics, Inc.

9490 NeoGenomics Way

33912, Fort Myers

http://www.neogenomics.com

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Medical & Diagnostic Laboratories

	1st Jan change	Capi.
SONIC HEALTHCARE LIMITED	-19.89%	8.2B
RADNET, INC.	+71.21%	4.33B
DR. LAL PATHLABS LIMITED	+7.87%	2.82B
SYNLAB AG	-2.98%	2.64B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-57.71%	1.74B
FLEURY S.A.	-16.46%	1.5B
METROPOLIS HEALTHCARE LIMITED	+19.97%	1.26B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-50.19%	1.01B
VIJAYA DIAGNOSTIC CENTRE LIMITED	+15.69%	958M

Medical & Diagnostic Laboratories